🇺🇸 FDA

Drug profile · INN

pandemic influenza vaccine (h5n1) (live attenuated, nasal)

PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE)

J07BB03
Patents linked
0
News articles
0

Quick answer

pandemic influenza vaccine (h5n1) (live attenuated, nasal) (PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE)) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN pandemic influenza vaccine (h5n1) (live attenuated, nasal)
Brand PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE)
ATC code J07BB03

Frequently asked questions

What is pandemic influenza vaccine (h5n1) (live attenuated, nasal)?

pandemic influenza vaccine (h5n1) (live attenuated, nasal) (PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE)) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for pandemic influenza vaccine (h5n1) (live attenuated, nasal)?

PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA (PREVIOUSLY PANDEMIC INFLUENZA VACCINE H5N1 MEDIMMUNE) is a marketed brand name for pandemic influenza vaccine (h5n1) (live attenuated, nasal). Check FDA Drugs@FDA for the current US label holder and prescribing information.